These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10751545)

  • 21. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.
    Baker E; Vitolo ML; Webb J
    Biochem Pharmacol; 1985 Sep; 34(17):3011-7. PubMed ID: 4038321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An in vivo evaluation of iron-chelating drugs derived from pyridoxal and its analogs.
    Johnson DK; Pippard MJ; Murphy TB; Rose NJ
    J Pharmacol Exp Ther; 1982 May; 221(2):399-403. PubMed ID: 7077535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative treatment paradigm for thalassemia using iron chelators.
    Szuber N; Buss JL; Soe-Lin S; Felfly H; Trudel M; Ponka P
    Exp Hematol; 2008 Jul; 36(7):773-85. PubMed ID: 18456387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Relationship of the lipophilicity of the apochelator to its ability to mobilise iron from reticulocytes in vitro.
    Ponka P; Richardson DR; Edward JT; Chubb FL
    Can J Physiol Pharmacol; 1994 Jun; 72(6):659-66. PubMed ID: 7954097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyridoxal isonicotinoyl hydrazone and its analogues.
    Buss JL; Hermes-Lima M; Ponka P
    Adv Exp Med Biol; 2002; 509():205-29. PubMed ID: 12572996
    [No Abstract]   [Full Text] [Related]  

  • 26. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.
    Hašková P; Kovaříková P; Koubková L; Vávrová A; Macková E; Simůnek T
    Free Radic Biol Med; 2011 Feb; 50(4):537-49. PubMed ID: 21147217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress and autologous immunoglobulin G binding to band 3 dimers in newborn erythrocytes.
    Rossi V; Leoncini S; Signorini C; Buonocore G; Paffetti P; Tanganelli D; Ciccoli L; Comporti M
    Free Radic Biol Med; 2006 Mar; 40(5):907-15. PubMed ID: 16520242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells.
    Buss JL; Arduini E; Shephard KC; Ponka P
    Biochem Pharmacol; 2003 Feb; 65(3):349-60. PubMed ID: 12527328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.
    Jansová H; Bureš J; Macháček M; Hašková P; Jirkovská A; Roh J; Wang Q; Franz KJ; Kovaříková P; Šimůnek T
    Toxicology; 2016 Mar; 350-352():15-24. PubMed ID: 27046792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress.
    Jansová H; Kubeš J; Reimerová P; Štěrbová-Kovaříková P; Roh J; Šimůnek T
    Chem Res Toxicol; 2018 Nov; 31(11):1151-1163. PubMed ID: 30395451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
    Lim CK; Kalinowski DS; Richardson DR
    Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process.
    Richardson DR
    Biochim Biophys Acta; 1997 May; 1320(1):45-57. PubMed ID: 9186779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.
    Hershko C; Avramovici-Grisaru S; Link G; Gelfand L; Sarel S
    J Lab Clin Med; 1981 Jul; 98(1):99-108. PubMed ID: 7252329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties.
    Buss JL; Neuzil J; Gellert N; Weber C; Ponka P
    Biochem Pharmacol; 2003 Jan; 65(2):161-72. PubMed ID: 12504792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pyridoxal isonicotinoyl hydrazone and analogs on iron metabolism in hepatocytes and macrophages in culture.
    Richardson D; Baker E; Ponka P; Wilairat P; Vitolo ML; Webb J
    Birth Defects Orig Artic Ser; 1988; 23(5B):81-8. PubMed ID: 3390577
    [No Abstract]   [Full Text] [Related]  

  • 36. Iron release and erythrocyte damage in allyl alcohol intoxication in mice.
    Ferrali M; Ciccoli L; Signorini C; Comporti M
    Biochem Pharmacol; 1990 Oct; 40(7):1485-90. PubMed ID: 2222504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron release in erythrocytes from patients with beta-thalassemia.
    Ciccoli L; Signorini C; Scarano C; Rossi V; Bambagioni S; Ferrali M; Comporti M
    Free Radic Res; 1999 May; 30(5):407-13. PubMed ID: 10342333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron released from an erythrocyte lysate by oxidative stress is diffusible and in redox active form.
    Ferrali M; Signorini C; Ciccoli L; Comporti M
    FEBS Lett; 1993 Mar; 319(1-2):40-4. PubMed ID: 8454059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death.
    Simůnek T; Boer C; Bouwman RA; Vlasblom R; Versteilen AM; Sterba M; Gersl V; Hrdina R; Ponka P; de Lange JJ; Paulus WJ; Musters RJ
    J Mol Cell Cardiol; 2005 Aug; 39(2):345-54. PubMed ID: 15978614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of protection of alveolar type II cells against paraquat-induced cytotoxicity by deferoxamine.
    van der Wal NA; van Oirschot JF; van Dijk A; Verhoef J; van Asbeck BS
    Biochem Pharmacol; 1990 Jun; 39(11):1665-71. PubMed ID: 2160815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.